Showing 4 posts of 4 posts found.


OncoMed initiates Phase Ib immuno-oncology combination clinical trial

March 18, 2016
Medical Communications, Research and Development Merck, OncoMed, clinical trial, demcizumab, immuno-oncology, immuno-oncology combination, pembrolizumab, phase ib

OncoMed (NASDAQ: OMED) has announced the beginning of its Phase Ib clinical trial to investigate if the combination of demcizumab …

Celgene image

Celgene signs $177 million OncoMed deal

December 4, 2013
Research and Development, Sales and Marketing Cancer, Celgene, OncoMed, stem cell

Celgene Corporation is paying OncoMed Pharmaceuticals $177.25 million to get access to its pipeline as part of a deal to …

Anti-cancer stem cell drug starts clinical trials

January 14, 2011
Research and Development Cancer, GSK, GlaxoSmithKline, OMP-21M18, OMP-59R5, OncoMed, Stem cells, advanced solid tumour cancers

OncoMed and GSK’s novel anti cancer stem cell drug OMP-59R5 has begun clinical trials and could represent the future direction …

Bayer signs cancer stem cell research deal

June 18, 2010
Research and Development Bayer Schering Pharma, Cancer, OncoMed, Stem cells

Bayer Schering Pharma has teamed up with a US oncology specialist to develop novel antibodies, protein therapeutics and small molecules …

Latest content